Evidence map›Paper›PMID 26324798›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2015

Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?

Sergio Harari, Marc Humbert, Francesco Blasi, Harold R Collard, Marco Matucci-Cerinic, Gerald Simonneau, Carlo Vancheri, Athol U Wells, Vincent Cottin

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Rare pulmonary diseases: a common fight.European respiratory review : an official journal of the European Respiratory Society · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sergio HarariU.O. di Pneumologia e Terapia Semi-Intensiva Respiratoria, Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, Ospedale San Giuseppe, MultiMedica IRCCS, Milan, Italy sharari@ilpolmone.it.
Marc HumbertUniv. Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France UMR_S 999, Univ. Paris-Sud, INSERM, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France.
Francesco BlasiDept of Pathophysiology and Transplantation, University of Milan, IRCCS Fondazione Ospedale Maggiore, Policlinico Cà Granda, Milan, Italy.
Harold R CollardUniversity of California San Francisco, San Francisco, CA, USA.
Marco Matucci-CerinicDept of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence, Florence, Italy.
Gerald SimonneauUniv. Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Service de Pneumologie, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France UMR_S 999, Univ. Paris-Sud, INSERM, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France.
Carlo VancheriDept of Clinical and Experimental Biomedicine, Section of Respiratory Diseases, Regional Center for Interstitial and Rare Lung Diseases, University of Catania, Policlinico "G. Rodolico", Catania, Italy.
Athol U WellsRoyal Brompton and Harefield NHS Foundation Trust, London, UK.
Vincent CottinHospices Civils de Lyon, Hôpital Louis Pradel, Service de Pneumologie, Centre de Référence National des Maladies Pulmonaires Rares, Lyon, France Université de Lyon, Université Lyon I, INRA, UMR754 INRA, Vetagrosup EPHE IFR 128, Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Orphan Drug ProductionBiomedical ResearchCongresses as TopicForecastingHumansLungLung DiseasesRare DiseasesRespiratory System AgentsRespiratory System Agents

Identifiers

PMID26324798
PMCPMC9487678

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.